{"gene":"POLDIP2","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2003,"finding":"PDIP38 (POLDIP2) was identified as a binding partner of the p50 subunit of DNA polymerase delta and of PCNA, confirmed by GST pulldown assays, PCNA overlay experiments, co-immunoprecipitation from calf thymus and mammalian cell extracts, immunoaffinity chromatography, and native gel electrophoresis.","method":"Yeast two-hybrid, GST pulldown, PCNA overlay, co-immunoprecipitation, immunoaffinity chromatography, native gel electrophoresis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal biochemical methods (pulldown, overlay, CoIP, affinity chromatography) in a single rigorous study","pmids":["12522211"],"is_preprint":false},{"year":2005,"finding":"PDIP38 localizes predominantly to the mitochondrial matrix (not nuclear) in HeLa cells, where it co-immunoprecipitates with mitochondrial transcription factor A (TFAM) and mitochondrial single-stranded DNA binding protein (mtSSB), and crosslinks to mtSSB, the 60 kDa heat shock protein, and a Lon protease homolog, indicating association with the mitochondrial DNA nucleoid.","method":"Subcellular fractionation, proteinase K protection assay, co-immunoprecipitation, formaldehyde crosslinking","journal":"Journal of biochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal CoIP plus crosslinking plus protease-protection fractionation, multiple orthogonal methods in one study","pmids":["16428295"],"is_preprint":false},{"year":2008,"finding":"PDIP38 localizes to the mitotic spindle throughout mitosis, and its loss-of-function (antibody injection or siRNA silencing) causes spindle organization defects, aberrant chromosome segregation, and multinucleated cells.","method":"Immunofluorescence/live imaging, antibody microinjection, siRNA knockdown, cell biology assays","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization experiment with functional consequence via two independent loss-of-function approaches (antibody injection and siRNA), single lab","pmids":["18843206"],"is_preprint":false},{"year":2009,"finding":"Poldip2 associates with p22phox, Nox1, and Nox4, colocalizes with p22phox at sites of Nox4 localization, and increases Nox4 enzymatic activity ~3-fold, thereby positively regulating basal ROS production (superoxide and H2O2) in vascular smooth muscle cells. Poldip2 overexpression activates RhoA, strengthens focal adhesions, and increases stress fiber formation; these effects are blocked by dominant-negative RhoA. Depletion of Poldip2 or Nox4 causes loss of these structures, rescued by active RhoA.","method":"Yeast two-hybrid, co-immunoprecipitation, colocalization, NADPH oxidase activity assay, ROS measurement, RhoA activation assay, dominant-negative rescue, siRNA knockdown, overexpression","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal CoIP, enzymatic activity assay, genetic epistasis (dominant-negative rescue), multiple orthogonal methods, widely replicated","pmids":["19574552"],"is_preprint":false},{"year":2010,"finding":"PDIP38 directly interacts with TLS polymerase Polη via Polη's UBZ domain, and also interacts with Rev1 and Polζ (via Rev7). Depletion of PDIP38 increases Polη foci in undamaged cells and reduces cell survival after UV irradiation.","method":"Direct protein interaction assays, co-immunoprecipitation, siRNA knockdown, immunofluorescence, UV survival assay","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct interaction mapping to specific domain, functional consequence of knockdown, single lab with multiple orthogonal methods","pmids":["20554254"],"is_preprint":false},{"year":2013,"finding":"In response to UV irradiation (or transcriptional stress), PDIP38 is translocated to nuclear speckles/spliceosomes, and its depletion (shRNA) greatly reduces UV-induced alternative splicing of MDM2 transcripts.","method":"Immunofluorescence with nuclear subcompartment markers, shRNA knockdown, nested RT-PCR for alternative splicing","journal":"Cell cycle (Georgetown, Tex.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with functional consequence (alternative splicing), two orthogonal methods, single lab","pmids":["23989611"],"is_preprint":false},{"year":2014,"finding":"Poldip2 regulates focal adhesion turnover and VSMC migration via Nox4/RhoA/FAK-dependent signaling: overexpression blocks focal adhesion dissolution and sustains H2O2 in focal adhesions; Nox4 silencing prevents focal adhesion stabilization by Poldip2; RhoA inhibition blocks Poldip2-mediated attenuation of focal adhesion dissolution; overexpression of RhoA or FAK reverses the loss of focal adhesions induced by Poldip2 knockdown.","method":"Adenoviral overexpression, siRNA knockdown, live imaging of focal adhesion dynamics, RhoA activity assay, H2O2 measurement in focal adhesions, traction force microscopy","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis established by multiple rescue experiments (RhoA, FAK, Nox4), live imaging with functional readout, multiple orthogonal methods","pmids":["25063792"],"is_preprint":false},{"year":2014,"finding":"In kidney myofibroblasts, RhoA/ROCK signaling acts upstream of Poldip2-dependent Nox4 regulation and ROS production during TGF-β1-induced myofibroblast activation; inhibition of RhoA (siRNA) or ROCK (Y-27632) significantly reduced Poldip2 and Nox4 protein and NADPH oxidase activity.","method":"siRNA knockdown, pharmacological inhibition (Y-27632), NADPH oxidase activity assay, Western blotting","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic and pharmacological epistasis, single lab, multiple inhibitor approaches","pmids":["24872317"],"is_preprint":false},{"year":2014,"finding":"Poldip2 knockout mouse embryonic fibroblasts display reduced proliferation (not due to apoptosis or senescence), increased autophagy (elevated LC3b), G1/G2M arrest with reduced S-phase cells, increased p53 S20 phosphorylation and Sirt1, downregulation of Cdk1 and CyclinA2, and increased p21CIP1; the Cdk1/CyclinA2 changes are reversed by SV40 large T-antigen (implicating E2F pathway), while p21 increase is not.","method":"Gene-trap mouse model, flow cytometry, Western blotting, population doubling, SV40 large T-antigen rescue experiment","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KO with defined cellular phenotype, partial pathway placement via SV40 rescue, single lab","pmids":["24797518"],"is_preprint":false},{"year":2015,"finding":"POLDIP2 promotes Tau aggregation through impairment of autophagy (and partially proteasome) activity; this activity resides in the DUF525 domain. Knockdown of Drosophila POLDIP2 homolog CG12162 attenuated Tau overexpression-induced neurodegeneration and extended lifespan of Tau(R406W) transgenic flies.","method":"cDNA expression library cell-based screen, ectopic overexpression/knockdown, Tau aggregation assay, autophagy/proteasome activity assay, domain deletion analysis, Drosophila genetic model","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — domain-level functional mapping, in vivo Drosophila validation, single lab","pmids":["25930997"],"is_preprint":false},{"year":2016,"finding":"PolDIP2 directly interacts with PrimPol's catalytic domain, stimulates PrimPol's polymerase activity and processivity, enhances dNTP/DNA binding, and promotes error-free bypass of 8-oxoG lesions. PolDIP2 depletion in human cells reduces replication fork rates similarly to PrimPol-/- cells; PolDIP2 depletion in PrimPol-/- cells causes no further decrease, placing them in the same epistasis group.","method":"Protein interaction mapping, in vitro polymerase assay, processivity assay, 8-oxoG bypass assay, DNA fiber assay (replication fork rates), siRNA knockdown, epistasis analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro reconstitution of stimulation, mutagenesis/domain mapping, genetic epistasis, multiple orthogonal methods in one study","pmids":["26984527"],"is_preprint":false},{"year":2018,"finding":"Poldip2 is a nuclear-encoded mitochondrial protein that controls lipoylation of pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (αKGDH) complexes by regulating the ClpP protease complex and degradation of the lipoate-activating enzyme ACSM1. Poldip2 deficiency reduces lipoylation, represses mitochondrial respiration, stabilizes HIF-1α (via loss of substrate inhibition of PHDs), and induces metabolic reprogramming resembling hypoxia/cancer adaptation. Poldip2 expression is repressed by hypoxia and basally suppressed in triple-negative cancer cells.","method":"Genetic knockout/knockdown, metabolic flux analysis, lipoylation assays, mitochondrial respiration (Seahorse), HIF-1α stabilization assay, protease complex analysis, overexpression rescue","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal biochemical methods, mechanistic pathway dissection with rescue experiments, single rigorous study with broad validation","pmids":["29434038"],"is_preprint":false},{"year":2018,"finding":"Poldip2/NOX4 activates NOX4 during integrin-mediated cell adhesion, leading to H2O2-mediated sulfenylation of filamentous actin (F-actin) at Cys272 and Cys374; oxidized F-actin promotes its binding to vinculin, facilitating focal adhesion maturation and cell migration. Depletion of Poldip2 or NOX4, or scavenging H2O2, inhibits F-actin oxidation; actin point mutants (C272A/C374A) that resist oxidation impair vinculin binding and migration.","method":"SiRNA knockdown, overexpression, H2O2 measurement, sulfenylation assay (DCP-Bio1), co-immunoprecipitation, point mutagenesis of actin, cell adhesion/migration assays","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — site-specific mutagenesis combined with biochemical assays and functional rescue, multiple orthogonal methods","pmids":["30354218"],"is_preprint":false},{"year":2018,"finding":"Poldip2 knockdown in rat aortic smooth muscle cells reduces serum-induced proliferation and PCNA expression, and upregulates p21. siRNA-mediated downregulation of p21 rescues the proliferation inhibition caused by Poldip2 knockdown, placing p21 downstream of Poldip2 in VSMC proliferation control.","method":"siRNA knockdown, cell proliferation assay, Western blotting, epistasis by p21 siRNA rescue, neointima formation in mouse femoral artery wire injury model","journal":"Laboratory investigation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis (p21 rescue), in vivo and in vitro corroboration, single lab","pmids":["30237457"],"is_preprint":false},{"year":2019,"finding":"Poldip2 mediates LPS-induced blood-brain barrier disruption by regulating NF-κB subunit p65 nuclear translocation and downstream Cox-2/prostaglandin E2 induction in brain endothelial cells; heterozygous deletion of Poldip2 protects against BBB permeability, and Cox-2 inhibition (meloxicam) reverses BBB disruption in WT but not Poldip2+/- mice.","method":"Poldip2+/- mouse model, Evans blue permeability assay, immunoblotting, ELISA, siRNA knockdown in brain endothelial cells, immunofluorescence of p65 translocation, FITC-dextran transwell assay","journal":"Journal of neuroinflammation","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic model corroborated by in vitro siRNA and pharmacological epistasis, multiple orthogonal methods","pmids":["31779628"],"is_preprint":false},{"year":2019,"finding":"Poldip2 deficiency induces a highly differentiated VSMC phenotype through upregulation of the hexosamine biosynthetic pathway and OGT-mediated protein O-GlcNAcylation, which inhibits a nuclear ubiquitin proteasome system responsible for SRF stabilization and KLF4 repression; Poldip2-deficient VSMCs resist dedifferentiation and macrophage-like conversion in response to cholesterol or PDGF.","method":"Genetic knockdown/knockout (in vitro and in vivo mouse aorta), RNA-seq, Western blotting, UPS activity assays, OGT inhibition, cholesterol/PDGF challenge","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo and in vitro corroboration, mechanistic pathway placement via OGT inhibition and UPS activity assays, multiple orthogonal methods","pmids":["31656131"],"is_preprint":false},{"year":2019,"finding":"PDIP38 shifts DNA damage tolerance in mammalian and chicken cells from template switching (TS) toward translesion synthesis (TLS): PDIP38-/- cells show increased immunoglobulin gene conversion (TS) and reduced non-templated hypermutation (TLS) in DT40, and increased sister chromatid exchanges in both DT40 and human TK6 cells, without increased sensitivity to UV or H2O2.","method":"Gene disruption (CRISPR/gene targeting) in DT40 and TK6, Ig V gene sequence analysis, sister chromatid exchange assay, UV/H2O2 sensitivity assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis established in two independent cell systems with multiple assays, mechanistically defining TLS vs TS balance","pmids":["30840704"],"is_preprint":false},{"year":2020,"finding":"Human PDIP38 is directed to the mitochondrial matrix in a membrane-potential-dependent manner. Its N-terminal YccV-like domain (SH3-like β-barrel) interacts specifically with CLPX via CLPX's N-terminal zinc-binding domain adaptor docking loop. Its C-terminal DUF525 domain forms an immunoglobulin-like β-sandwich with a conserved substrate-binding pocket. PDIP38 modulates CLPX substrate specificity and protects CLPX from LONM-mediated degradation, stabilizing cellular CLPX levels.","method":"Crystal structure, biochemical reconstitution, domain interaction mapping, mitochondrial import assay (membrane potential dependence), CLPXP substrate specificity assay, LONM degradation assay","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure with functional validation, biochemical reconstitution of CLPXP regulation, multiple orthogonal methods in one rigorous study","pmids":["33159171"],"is_preprint":false},{"year":2021,"finding":"Crystal structure of POLDIP2 to 2.8 Å reveals a compact two-domain β-strand-rich globular fold comprising YccV (SH3-like β-barrel) and DUF525 (immunoglobulin-like β-sandwich) domains with a conserved central channel containing a modified cysteine residue; molecular dynamics reveals a highly dynamic N-terminal region tethered by an extended linker, which likely mediates interactions with binding partners including PrimPol and PCNA.","method":"X-ray crystallography, circular dichroism, SAXS, molecular dynamics simulation, ab initio modelling","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure at 2.8 Å with orthogonal SAXS and CD validation, single lab","pmids":["33884680"],"is_preprint":false},{"year":2021,"finding":"PolDIP2 uses a flexible loop to interact with the C-terminal ApaG-like (DUF525) domain of PolDIP2 on PrimPol's catalytic domain; a unique arginine cluster in PolDIP2 is required for increasing PrimPol's primer-template and dNTP binding affinities, thereby enhancing nucleotide incorporation efficiency and processivity.","method":"In vitro polymerase assay, dNTP/DNA binding affinity measurements, mutagenesis of PolDIP2 arginine cluster, protein interaction mapping","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis of specific residues, binding affinity quantification, mechanistic dissection of stimulation mechanism","pmids":["33533925"],"is_preprint":false},{"year":2021,"finding":"PolDIP2 directly interacts with Tau protein in vitro and inhibits Tau oligomer formation and amyloid fibril growth, as shown by thioflavin-T kinetic assays, Tau oligomer dot-blot, and atomic force microscopy single-molecule analysis.","method":"Thioflavin-T aggregation kinetics, Tau oligomer dot-blot, atomic force microscopy, direct protein interaction assay","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with multiple complementary methods, single lab, no cellular or in vivo validation in this study","pmids":["34071254"],"is_preprint":false},{"year":2021,"finding":"Poldip2 promotes VCAM-1 induction in brain endothelial cells following ischemia via activation of focal adhesion kinase (FAK); FAK activation was identified as a critical intermediary in Poldip2-mediated VCAM-1 induction, and Poldip2 depletion in vivo attenuated myeloid cell infiltration and adhesion molecule induction after cerebral ischemia.","method":"Poldip2+/- mouse cerebral ischemia model, flow cytometry, RT-PCR, siRNA knockdown in brain endothelial cells, FAK activation assay, Western blotting","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo and in vitro corroboration, FAK epistasis established in vitro, single lab","pmids":["33692398"],"is_preprint":false},{"year":2022,"finding":"Endothelial Poldip2 regulates sepsis-induced lung injury via RhoA pathway activation: endothelial-specific Poldip2 knockout reduces LPS-induced lung leukocyte infiltration, inflammatory gene expression, and VCAM1 induction; in vitro, Poldip2 knockdown reduces TNFα-induced endothelial permeability, VE-cadherin disruption, and RhoA activation, with redistribution of active RhoA away from cell edges.","method":"Endothelial-specific conditional knockout mouse, BAL/lung tissue analysis, qPCR, siRNA knockdown in human pulmonary endothelial cells, transendothelial resistance assay, VE-cadherin immunofluorescence, RhoA activity assay","journal":"Cardiovascular research","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific in vivo knockout corroborated by in vitro mechanistic studies, multiple orthogonal methods","pmids":["34528082"],"is_preprint":false},{"year":2022,"finding":"Poldip2 is repressed under hypoxia by a mechanism requiring activation of the EZH2 repressive complex downstream of CDK2; Poldip2 repression is required for CCN2/CTGF expression via metabolic inhibition of the ubiquitin-proteasome system leading to SRF stabilization; pharmacological or genetic CDK2 inhibition reverses Poldip2 downregulation, UPS inhibition, and fibrotic gene expression.","method":"Hypoxia exposure, CDK2 inhibition (pharmacological and siRNA), EZH2 inhibition, UPS activity assay, Western blotting, gene expression analysis","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway epistasis with multiple inhibitor approaches, single lab","pmids":["36596387"],"is_preprint":false},{"year":2022,"finding":"Myeloid Poldip2 is required for β2-integrin activation and Pyk2 phosphorylation in neutrophils, facilitating neutrophil adhesion to activated endothelium and transmigration; myeloid-specific Poldip2 knockout reduces LPS-induced lung leukocyte infiltration without affecting neutrophil surface β2-integrin expression, ROS production, NET formation, or cytokine induction.","method":"Myeloid-specific Poldip2 knockout mouse, BAL cell counts, β2-integrin activation assay, Pyk2 phosphorylation, neutrophil adhesion/transmigration assay, ROS assay, NET formation assay","journal":"Journal of the American Heart Association","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-type-specific KO with mechanistic dissection (integrin activation, Pyk2), single lab, multiple functional readouts","pmids":["35535614"],"is_preprint":false},{"year":2023,"finding":"Poldip2 negatively modulates NADPH oxidase 2 (Nox2) activity in neutrophil membranes (~2.5-fold downregulation) by interacting with the regulatory subunit p47phox (not p22phox), trapping p47phox and preventing Nox2 assembly; this is opposite to its positive regulation of Nox4.","method":"In vitro NADPH oxidase activity assay with fractionated neutrophil membranes, recombinant purified Poldip2, protein interaction assays","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified proteins, mechanistic distinction from Nox4 regulation, single lab","pmids":["36828293"],"is_preprint":false},{"year":2024,"finding":"POLDIP2 serves as a heme-sensing adaptor protein for the mitochondrial protease CLPXP: it directly recognizes heme-bound ALAS and drives assembly of the ALAS-CLPXP degradation complex for heme-induced negative feedback degradation of ALAS; loss of POLDIP2 strongly impairs ALAS turnover in cells. The C-terminal element of ALAS (truncated in X-linked dominant protoporphyria) is dispensable for POLDIP2 interaction but required for CLPXP-mediated degradation.","method":"Biochemical reconstitution, pulldown with heme-bound ALAS, ALAS turnover assay in cells (POLDIP2 knockout), domain deletion analysis","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of the full degradation complex, cellular validation of ALAS turnover, mechanistic domain dissection, single rigorous preprint","pmids":[],"is_preprint":true},{"year":2025,"finding":"In Drosophila spermatogenesis, Poldip2 is a mitochondrial matrix protein that binds mtDNA and is required for paternal mtDNA elimination; disruption of poldip2 causes substantial mtDNA retention in mature sperm and paternal mtDNA transmission. ClpX (key CLPXP component) interacts with Poldip2 and co-regulates mtDNA elimination in spermatids.","method":"Forward genetic screen, genetic disruption, imaging, biochemical analyses, ChIP assay, co-immunoprecipitation","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — forward genetic screen, ChIP and CoIP validation, functional consequence in vivo, single lab in Drosophila model","pmids":["39934413"],"is_preprint":false},{"year":2024,"finding":"Poldip2 promotes SMAD3 activation and facilitates its nuclear translocation by directly interacting with SMAD3, enhancing expression of fibrosis markers (MMP9, COL-1, FN, CTGF) via TGF-β1/SMAD3 signaling in retinal pigment epithelial cells exposed to high glucose.","method":"siRNA/shRNA knockdown (in vitro and in vivo AAV9), co-immunoprecipitation (Poldip2-SMAD3 interaction), Western blotting, immunofluorescence of SMAD3 nuclear translocation","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CoIP establishing direct interaction, nuclear translocation assay, in vivo and in vitro corroboration, single lab","pmids":["38968428"],"is_preprint":false}],"current_model":"POLDIP2 (PDIP38) is a multifunctional mitochondrial matrix adaptor protein that: (1) activates Nox4 (and negatively regulates Nox2 via p47phox interaction) to generate H2O2 for cytoskeletal remodeling—oxidizing F-actin to promote vinculin binding, focal adhesion maturation, and VSMC migration via RhoA/FAK; (2) controls mitochondrial oxidative metabolism by regulating ClpP protease-dependent degradation of ACSM1 to maintain PDH and αKGDH lipoylation, and serves as a heme-sensing adaptor delivering ALAS to CLPXP for negative-feedback degradation; (3) interacts with and stimulates replication-associated polymerases (DNA pol δ p50/PCNA, PrimPol via its DUF525 arginine cluster, and TLS polymerases Polη, Rev1, Polζ), shifting DNA damage tolerance toward translesion synthesis; (4) localizes to the mitotic spindle where it is required for chromosome segregation; and (5) translocates to nuclear speckles upon UV stress to facilitate MDM2 alternative splicing."},"narrative":{"mechanistic_narrative":"POLDIP2 (PDIP38) is a compact two-domain adaptor protein—an N-terminal YccV-like SH3 β-barrel and a C-terminal DUF525 immunoglobulin-like β-sandwich [PMID:33884680]—that operates as a multifunctional scaffold across mitochondrial, redox, and DNA-transaction processes. In mitochondria, where it is imported to the matrix in a membrane-potential-dependent manner and associates with the mtDNA nucleoid [PMID:16428295, PMID:33159171], it controls oxidative metabolism by regulating the ClpP/CLPXP protease: its YccV domain docks CLPX while its DUF525 domain shapes substrate specificity and protects CLPX from LONM-mediated degradation [PMID:33159171]. Through this protease axis POLDIP2 governs ClpP-dependent turnover of the lipoate-activating enzyme ACSM1 to maintain PDH and αKGDH lipoylation and mitochondrial respiration, with its loss stabilizing HIF-1α and reprogramming metabolism [PMID:29434038], and it acts as a heme-sensing adaptor that delivers heme-bound ALAS to CLPXP for negative-feedback degradation. As a redox regulator, POLDIP2 binds the NADPH oxidase subunit p22phox and Nox4, activating Nox4-derived H2O2 to drive RhoA/FAK-dependent focal adhesion maturation and vascular smooth muscle cell migration—including sulfenylation of F-actin at Cys272/Cys374 that promotes vinculin binding [PMID:19574552, PMID:25063792, PMID:30354218]—while conversely restraining Nox2 by sequestering p47phox [PMID:36828293]. In DNA metabolism, POLDIP2 binds the p50 subunit of DNA polymerase δ and PCNA [PMID:12522211] and directly stimulates the polymerase activity and processivity of PrimPol via an arginine cluster in its DUF525 domain, promoting error-free 8-oxoG bypass and supporting replication fork progression in the same epistasis group as PrimPol [PMID:26984527, PMID:33533925]; it also engages translesion polymerases (Polη, Rev1, Polζ) and shifts DNA damage tolerance from template switching toward translesion synthesis [PMID:20554254, PMID:30840704]. POLDIP2 additionally localizes to the mitotic spindle and is required for proper chromosome segregation [PMID:18843206]. In vivo, endothelial, myeloid, and vascular POLDIP2 promote inflammatory adhesion, barrier disruption, and fibrotic signaling through RhoA, FAK/Pyk2-integrin, NF-κB, and TGF-β1/SMAD3 pathways [PMID:31779628, PMID:34528082, PMID:35535614, PMID:38968428].","teleology":[{"year":2003,"claim":"Established POLDIP2's first molecular partners, linking it to the replication/repair machinery before any pathway context existed.","evidence":"Yeast two-hybrid plus orthogonal biochemistry (GST pulldown, PCNA overlay, CoIP) identifying binding to DNA pol δ p50 and PCNA","pmids":["12522211"],"confidence":"High","gaps":["No functional consequence of the interaction defined","No structural basis for binding established at this stage"]},{"year":2005,"claim":"Resolved where POLDIP2 acts by showing it is predominantly a mitochondrial matrix nucleoid protein, reframing it beyond a nuclear polymerase factor.","evidence":"Subcellular fractionation, proteinase K protection, CoIP and crosslinking to TFAM, mtSSB, HSP60 and a Lon homolog in HeLa cells","pmids":["16428295"],"confidence":"High","gaps":["Functional role at the nucleoid not defined","Relationship between mitochondrial and nuclear pools unresolved"]},{"year":2008,"claim":"Added a mitotic function, showing POLDIP2 is required for spindle integrity and chromosome segregation.","evidence":"Immunofluorescence/live imaging plus antibody microinjection and siRNA loss-of-function in mammalian cells","pmids":["18843206"],"confidence":"Medium","gaps":["Molecular partners at the spindle unidentified","Mechanism connecting spindle role to other functions unknown"]},{"year":2009,"claim":"Defined POLDIP2 as a positive regulator of Nox4-derived ROS driving cytoskeletal/focal adhesion remodeling, opening its redox-signaling role.","evidence":"Y2H, reciprocal CoIP with p22phox/Nox4, NADPH oxidase activity and ROS assays, RhoA activation, dominant-negative RhoA rescue in VSMCs","pmids":["19574552"],"confidence":"High","gaps":["Molecular target of H2O2 in the cytoskeleton not yet identified","Link to mitochondrial functions unaddressed"]},{"year":2010,"claim":"Connected POLDIP2 to translesion synthesis by mapping direct interactions with TLS polymerases and a UV-survival phenotype.","evidence":"Direct interaction assays (Polη UBZ domain, Rev1, Polζ via Rev7), siRNA knockdown, Polη foci imaging, UV survival in human cells","pmids":["20554254"],"confidence":"Medium","gaps":["Directionality of TLS regulation not quantified","In vitro reconstitution of polymerase stimulation absent"]},{"year":2014,"claim":"Established mechanistic epistasis placing POLDIP2 upstream of Nox4/RhoA/FAK in focal adhesion turnover and migration, and embedded it in a RhoA/ROCK feedback loop.","evidence":"Adenoviral overexpression, siRNA, live focal-adhesion imaging, traction force microscopy, RhoA/FAK rescue in VSMCs; RhoA/ROCK inhibition in kidney myofibroblasts","pmids":["25063792","24872317"],"confidence":"High","gaps":["Direct oxidative substrate still not identified at this stage","Generalizability beyond vascular/fibroblast cells unclear"]},{"year":2014,"claim":"Linked POLDIP2 loss to a cell-cycle/proliferation phenotype, implicating E2F-driven Cdk1/CyclinA2 and p21 control.","evidence":"Gene-trap knockout MEFs, flow cytometry, Western blotting, SV40 large T-antigen rescue","pmids":["24797518"],"confidence":"Medium","gaps":["Mechanism connecting POLDIP2 to E2F/p21 not defined","p21 increase not explained by the SV40-rescuable pathway"]},{"year":2016,"claim":"Demonstrated direct enzymatic stimulation of PrimPol by POLDIP2, defining a concrete replication-fork function and shared epistasis group.","evidence":"Interaction mapping to PrimPol catalytic domain, in vitro polymerase/processivity and 8-oxoG bypass assays, DNA fiber assays, epistasis with PrimPol-/-","pmids":["26984527"],"confidence":"High","gaps":["Residue-level basis of stimulation not yet mapped","Contribution of mitochondrial vs nuclear pool unresolved"]},{"year":2018,"claim":"Defined POLDIP2's mitochondrial metabolic role through ClpP-dependent ACSM1 turnover controlling lipoylation, respiration, and HIF-1α stability.","evidence":"Knockout/knockdown, metabolic flux, lipoylation assays, Seahorse respiration, HIF-1α stabilization, protease analysis, rescue","pmids":["29434038"],"confidence":"High","gaps":["Direct biochemical link between POLDIP2 and ClpP activity not yet structurally defined","Cancer relevance correlative"]},{"year":2018,"claim":"Identified the molecular target of Nox4-derived H2O2 as F-actin, showing site-specific cysteine sulfenylation promotes vinculin binding and migration.","evidence":"siRNA/overexpression, DCP-Bio1 sulfenylation assay, CoIP, actin C272A/C374A point mutants, adhesion/migration assays","pmids":["30354218"],"confidence":"High","gaps":["Spatial coupling of Nox4 to actin not structurally resolved","Whether mitochondrial POLDIP2 contributes to this pool unaddressed"]},{"year":2018,"claim":"Extended the proliferation phenotype to vascular pathology, placing p21 downstream of POLDIP2 in VSMC proliferation and neointima formation.","evidence":"siRNA in rat aortic SMCs, proliferation/PCNA assays, p21 siRNA rescue, mouse femoral artery wire-injury model","pmids":["30237457"],"confidence":"Medium","gaps":["Mechanism of p21 regulation by POLDIP2 unknown","Relationship to redox vs metabolic functions unclear"]},{"year":2019,"claim":"Defined the directionality of POLDIP2 in DNA damage tolerance, showing it biases the balance from template switching toward translesion synthesis.","evidence":"Gene disruption in DT40 and TK6, Ig V gene conversion/hypermutation analysis, sister chromatid exchange, UV/H2O2 sensitivity assays","pmids":["30840704"],"confidence":"High","gaps":["Substrate selectivity among TLS polymerases not quantified","No structural basis for TS-vs-TLS choice"]},{"year":2019,"claim":"Expanded POLDIP2 into vascular phenotype control and inflammation, connecting it to O-GlcNAcylation/SRF/KLF4 and NF-κB/Cox-2 pathways.","evidence":"In vivo/in vitro knockout, RNA-seq, UPS activity and OGT inhibition assays (VSMC differentiation); Poldip2+/- mice, p65 translocation and Cox-2 epistasis (BBB)","pmids":["31656131","31779628"],"confidence":"High","gaps":["Direct molecular target linking POLDIP2 to OGT/UPS not identified","How a single adaptor coordinates these divergent pathways unresolved"]},{"year":2020,"claim":"Provided the structural and biochemical basis for mitochondrial adaptor function, showing domain-specific CLPX docking and protection from LONM degradation.","evidence":"Crystal structure, reconstitution, domain interaction mapping, import assay, CLPXP substrate-specificity and LONM degradation assays","pmids":["33159171"],"confidence":"High","gaps":["Full set of CLPXP substrates POLDIP2 selects not enumerated","Regulation of POLDIP2 import in vivo unaddressed"]},{"year":2021,"claim":"Delivered the full POLDIP2 structure and identified the DUF525 arginine cluster as the determinant of PrimPol stimulation.","evidence":"X-ray crystallography, CD, SAXS, MD simulation; in vitro polymerase and dNTP/DNA binding assays with arginine-cluster mutagenesis","pmids":["33884680","33533925"],"confidence":"High","gaps":["Role of the dynamic N-terminus in partner selection not fully defined","How one fold supports both mitochondrial and replication functions unresolved"]},{"year":2021,"claim":"Probed a direct POLDIP2–Tau interaction, with conflicting cellular versus in vitro effects on Tau aggregation.","evidence":"In vitro ThT kinetics, dot-blot, AFM (inhibits aggregation); earlier cell/Drosophila screen mapping pro-aggregation to DUF525","pmids":["34071254","25930997"],"confidence":"Medium","gaps":["In vitro and cellular outcomes are opposite and unreconciled","Physiological relevance to neurodegeneration uncertain"]},{"year":2022,"claim":"Established cell-type-specific in vivo roles in inflammation, dissecting endothelial RhoA/permeability and myeloid integrin/Pyk2 contributions.","evidence":"Endothelial-specific KO (sepsis lung injury, RhoA/VE-cadherin); myeloid-specific KO (β2-integrin activation, Pyk2); hypoxia/CDK2/EZH2 repression of POLDIP2","pmids":["34528082","35535614","36596387"],"confidence":"High","gaps":["Whether redox vs scaffolding activity drives each phenotype unresolved","Upstream signals selecting which pathway POLDIP2 engages unclear"]},{"year":2023,"claim":"Distinguished POLDIP2's opposing NADPH oxidase regulation, showing direct p47phox sequestration suppresses Nox2 assembly.","evidence":"In vitro NADPH oxidase assays with fractionated neutrophil membranes and recombinant POLDIP2, protein interaction assays","pmids":["36828293"],"confidence":"Medium","gaps":["Structural basis of p47phox sequestration not defined","In vivo relevance of Nox2 suppression not established"]},{"year":2024,"claim":"Defined POLDIP2 as a heme-sensing adaptor coupling ALAS turnover to CLPXP, integrating its protease-adaptor role with heme homeostasis.","evidence":"Biochemical reconstitution, pulldown of heme-bound ALAS, ALAS turnover in POLDIP2-KO cells, domain deletion (preprint)","pmids":[],"confidence":"High","gaps":["Preprint not yet peer-reviewed","Disease relevance to X-linked protoporphyria correlative"]},{"year":2025,"claim":"Showed a conserved in vivo mitochondrial function for the POLDIP2–ClpX axis in paternal mtDNA elimination during spermatogenesis.","evidence":"Forward genetic screen, genetic disruption, imaging, ChIP and CoIP in Drosophila","pmids":["39934413"],"confidence":"Medium","gaps":["Mechanism of mtDNA-targeted elimination not defined","Conservation in mammalian spermatogenesis untested"]},{"year":null,"claim":"It remains unknown how a single small two-domain adaptor mechanistically partitions among its mitochondrial protease, NADPH oxidase redox, replication/TLS polymerase, and spindle roles, and what regulates its distribution between organelles.","evidence":"","pmids":[],"confidence":"Low","gaps":["No unified model of pool partitioning between mitochondria and nucleus","No structure of POLDIP2 bound to its replication or oxidase partners","Regulation of context-specific function selection unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[17,26,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10,19,25,17]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[10,19]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,27]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[12]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[1,11,17,27]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,5]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[2]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[12,3]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,25]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[11,26]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[0,10,19]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[4,16]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[17,11,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,6,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[14,22,24]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[2]}],"complexes":["CLPXP protease","NADPH oxidase (Nox4/p22phox)","mtDNA nucleoid"],"partners":["CLPX","PRIMPOL","PCNA","NOX4","P22PHOX","P47PHOX","TFAM","SMAD3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y2S7","full_name":"Polymerase delta-interacting protein 2","aliases":["38 kDa DNA polymerase delta interaction protein","p38"],"length_aa":368,"mass_kda":42.0,"function":"Involved in DNA damage tolerance by regulating translesion synthesis (TLS) of templates carrying DNA damage lesions such as 8oxoG and abasic sites (PubMed:24191025). May act by stimulating activity of DNA polymerases involved in TLS, such as PRIMPOL and polymerase delta (POLD1) (PubMed:24191025, PubMed:26984527)","subcellular_location":"Mitochondrion matrix; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9Y2S7/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POLDIP2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":74,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"LSM14B","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/POLDIP2","total_profiled":1310},"omim":[{"mim_id":"611519","title":"POLYMERASE DELTA-INTERACTING PROTEIN 2; POLDIP2","url":"https://www.omim.org/entry/611519"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":255.8}],"url":"https://www.proteinatlas.org/search/POLDIP2"},"hgnc":{"alias_symbol":["PDIP38","DKFZP586F1524"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y2S7","domains":[{"cath_id":"2.60.40.1470","chopping":"68-108_128-355","consensus_level":"medium","plddt":93.9356,"start":68,"end":355}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2S7","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2S7-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y2S7-F1-predicted_aligned_error_v6.png","plddt_mean":79.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLDIP2","jax_strain_url":"https://www.jax.org/strain/search?query=POLDIP2"},"sequence":{"accession":"Q9Y2S7","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y2S7.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y2S7/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y2S7"}},"corpus_meta":[{"pmid":"19574552","id":"PMC_19574552","title":"Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells.","date":"2009","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/19574552","citation_count":363,"is_preprint":false},{"pmid":"24872317","id":"PMC_24872317","title":"RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species.","date":"2014","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24872317","citation_count":106,"is_preprint":false},{"pmid":"12522211","id":"PMC_12522211","title":"Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12522211","citation_count":99,"is_preprint":false},{"pmid":"31779628","id":"PMC_31779628","title":"Poldip2 mediates blood-brain barrier disruption in a model of sepsis-associated encephalopathy.","date":"2019","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/31779628","citation_count":91,"is_preprint":false},{"pmid":"36088760","id":"PMC_36088760","title":"Capsaicin ameliorates diabetic retinopathy by inhibiting poldip2-induced oxidative stress.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/36088760","citation_count":74,"is_preprint":false},{"pmid":"16428295","id":"PMC_16428295","title":"PDIP38 associates with proteins constituting the mitochondrial DNA nucleoid.","date":"2005","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16428295","citation_count":66,"is_preprint":false},{"pmid":"29434038","id":"PMC_29434038","title":"Poldip2 is an oxygen-sensitive protein that controls PDH and αKGDH lipoylation and activation to support metabolic adaptation in hypoxia and cancer.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/29434038","citation_count":56,"is_preprint":false},{"pmid":"25063792","id":"PMC_25063792","title":"Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization.","date":"2014","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25063792","citation_count":54,"is_preprint":false},{"pmid":"26984527","id":"PMC_26984527","title":"PolDIP2 interacts with human PrimPol and enhances its DNA polymerase activities.","date":"2016","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26984527","citation_count":49,"is_preprint":false},{"pmid":"20554254","id":"PMC_20554254","title":"Crosstalk between replicative and translesional DNA polymerases: PDIP38 interacts directly with Poleta.","date":"2010","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/20554254","citation_count":46,"is_preprint":false},{"pmid":"24797518","id":"PMC_24797518","title":"Poldip2 knockout results in perinatal lethality, reduced cellular growth and increased autophagy of mouse embryonic fibroblasts.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24797518","citation_count":39,"is_preprint":false},{"pmid":"31656131","id":"PMC_31656131","title":"Mitochondrial Protein Poldip2 (Polymerase Delta Interacting Protein 2) Controls Vascular Smooth Muscle Differentiated Phenotype by O-Linked GlcNAc (N-Acetylglucosamine) Transferase-Dependent Inhibition of a Ubiquitin Proteasome System.","date":"2019","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/31656131","citation_count":35,"is_preprint":false},{"pmid":"20158880","id":"PMC_20158880","title":"Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression.","date":"2010","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/20158880","citation_count":34,"is_preprint":false},{"pmid":"23989611","id":"PMC_23989611","title":"PDIP38 is translocated to the spliceosomes/nuclear speckles in response to UV-induced DNA damage and is required for UV-induced alternative splicing of MDM2.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23989611","citation_count":28,"is_preprint":false},{"pmid":"30354218","id":"PMC_30354218","title":"NOX4 (NADPH Oxidase 4) and Poldip2 (Polymerase δ-Interacting Protein 2) Induce Filamentous Actin Oxidation and Promote Its Interaction With Vinculin During Integrin-Mediated Cell Adhesion.","date":"2018","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/30354218","citation_count":25,"is_preprint":false},{"pmid":"30622219","id":"PMC_30622219","title":"Poldip2 deficiency protects against lung edema and vascular inflammation in a model of acute respiratory distress syndrome.","date":"2019","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/30622219","citation_count":22,"is_preprint":false},{"pmid":"25930997","id":"PMC_25930997","title":"Essential role of POLDIP2 in Tau aggregation and neurotoxicity via autophagy/proteasome inhibition.","date":"2015","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25930997","citation_count":21,"is_preprint":false},{"pmid":"18843206","id":"PMC_18843206","title":"PDIP38 is a novel mitotic spindle-associated protein that affects spindle organization and chromosome segregation.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18843206","citation_count":21,"is_preprint":false},{"pmid":"34528082","id":"PMC_34528082","title":"Endothelial Poldip2 regulates sepsis-induced lung injury via Rho pathway activation.","date":"2022","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/34528082","citation_count":20,"is_preprint":false},{"pmid":"30840704","id":"PMC_30840704","title":"PDIP38/PolDIP2 controls the DNA damage tolerance pathways by increasing the relative usage of translesion DNA synthesis over template switching.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30840704","citation_count":19,"is_preprint":false},{"pmid":"32790044","id":"PMC_32790044","title":"Poldip2 mediates blood-brain barrier disruption and cerebral edema by inducing AQP4 polarity loss in mouse bacterial meningitis model.","date":"2020","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/32790044","citation_count":19,"is_preprint":false},{"pmid":"33692398","id":"PMC_33692398","title":"Poldip2 controls leukocyte infiltration into the ischemic brain by regulating focal adhesion kinase-mediated VCAM-1 induction.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33692398","citation_count":18,"is_preprint":false},{"pmid":"33159171","id":"PMC_33159171","title":"Polymerase delta-interacting protein 38 (PDIP38) modulates the stability and activity of the mitochondrial AAA+ protease CLPXP.","date":"2020","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/33159171","citation_count":16,"is_preprint":false},{"pmid":"30237457","id":"PMC_30237457","title":"Poldip2 knockdown inhibits vascular smooth muscle proliferation and neointima formation by regulating the expression of PCNA and p21.","date":"2018","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30237457","citation_count":13,"is_preprint":false},{"pmid":"31634459","id":"PMC_31634459","title":"Matrine pre-treatment suppresses AGEs- induced HCSMCs fibrotic responses by regulating Poldip2/mTOR pathway.","date":"2019","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31634459","citation_count":13,"is_preprint":false},{"pmid":"35140544","id":"PMC_35140544","title":"Poldip2/Nox4 Mediates Lipopolysaccharide-Induced Oxidative Stress and Inflammation in Human Lung Epithelial Cells.","date":"2022","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/35140544","citation_count":12,"is_preprint":false},{"pmid":"38174114","id":"PMC_38174114","title":"Nanoscale coordination polymer Fe-DMY downregulating Poldip2-Nox4-H2O2 pathway and alleviating diabetic retinopathy.","date":"2023","source":"Journal of pharmaceutical analysis","url":"https://pubmed.ncbi.nlm.nih.gov/38174114","citation_count":12,"is_preprint":false},{"pmid":"33533925","id":"PMC_33533925","title":"A unique arginine cluster in PolDIP2 enhances nucleotide binding and DNA synthesis by PrimPol.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33533925","citation_count":11,"is_preprint":false},{"pmid":"29862022","id":"PMC_29862022","title":"Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma.","date":"2018","source":"F1000Research","url":"https://pubmed.ncbi.nlm.nih.gov/29862022","citation_count":10,"is_preprint":false},{"pmid":"29684384","id":"PMC_29684384","title":"Knockdown of POLDIP2 suppresses tumor growth and invasion capacity and is linked to unfavorable transformation ability and metastatic feature in non-small cell lung cancer.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29684384","citation_count":9,"is_preprint":false},{"pmid":"31351995","id":"PMC_31351995","title":"Hepatic deficiency of Poldip2 in type 2 diabetes dampens lipid and glucose homeostasis.","date":"2019","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/31351995","citation_count":8,"is_preprint":false},{"pmid":"35328424","id":"PMC_35328424","title":"MicroRNA 148a Suppresses Tuberculous Fibrosis by Targeting NOX4 and POLDIP2.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35328424","citation_count":8,"is_preprint":false},{"pmid":"32383114","id":"PMC_32383114","title":"A Multifunctional Protein PolDIP2 in DNA Translesion Synthesis.","date":"2020","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/32383114","citation_count":7,"is_preprint":false},{"pmid":"39934413","id":"PMC_39934413","title":"Poldip2 promotes mtDNA elimination during Drosophila spermatogenesis to ensure maternal inheritance.","date":"2025","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/39934413","citation_count":7,"is_preprint":false},{"pmid":"34076993","id":"PMC_34076993","title":"MIR31HG regulates the proliferation, migration and invasion of breast cancer by regulating the expression of POLDIP2.","date":"2021","source":"Journal of B.U.ON. : official journal of the Balkan Union of Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/34076993","citation_count":7,"is_preprint":false},{"pmid":"33884680","id":"PMC_33884680","title":"Crystal structure and molecular dynamics of human POLDIP2, a multifaceted adaptor protein in metabolism and genome stability.","date":"2021","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/33884680","citation_count":6,"is_preprint":false},{"pmid":"27918072","id":"PMC_27918072","title":"FGF Suppresses Poldip2 Expression in Osteoblasts.","date":"2017","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27918072","citation_count":5,"is_preprint":false},{"pmid":"34928942","id":"PMC_34928942","title":"Characterization of Poldip2 knockout mice: Avoiding incorrect gene targeting.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34928942","citation_count":5,"is_preprint":false},{"pmid":"36596387","id":"PMC_36596387","title":"Metabolic regulation of the proteasome under hypoxia by Poldip2 controls fibrotic signaling in vascular smooth muscle cells.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36596387","citation_count":5,"is_preprint":false},{"pmid":"36123704","id":"PMC_36123704","title":"ZEB1 regulates bone metabolism in osteoporotic rats through inducing POLDIP2 transcription.","date":"2022","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/36123704","citation_count":5,"is_preprint":false},{"pmid":"35535614","id":"PMC_35535614","title":"Myeloid Poldip2 Contributes to the Development of Pulmonary Inflammation by Regulating Neutrophil Adhesion in a Murine Model of Acute Respiratory Distress Syndrome.","date":"2022","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/35535614","citation_count":5,"is_preprint":false},{"pmid":"38968428","id":"PMC_38968428","title":"Overexpressed Poldip2 Incurs Retinal Fibrosis via the TGF-β1/SMAD3 Signaling Pathway in Diabetic Retinopathy.","date":"2024","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/38968428","citation_count":4,"is_preprint":false},{"pmid":"34071254","id":"PMC_34071254","title":"Human Polymerase δ-Interacting Protein 2 (PolDIP2) Inhibits the Formation of Human Tau Oligomers and Fibrils.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34071254","citation_count":4,"is_preprint":false},{"pmid":"40320136","id":"PMC_40320136","title":"Poldip2 Aggravates inflammation in diabetic retinopathy by impairing mitophagy via the AMPK/ULK1/Pink1 pathway.","date":"2025","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40320136","citation_count":3,"is_preprint":false},{"pmid":"36120334","id":"PMC_36120334","title":"Poldip2 knockdown protects against lipopolysaccharide-induced acute lung injury via Nox4/Nrf2/NF-κB signaling pathway.","date":"2022","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36120334","citation_count":3,"is_preprint":false},{"pmid":"36828293","id":"PMC_36828293","title":"New insights in the molecular regulation of the NADPH oxidase 2 activity: Negative modulation by Poldip2.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36828293","citation_count":3,"is_preprint":false},{"pmid":"36795578","id":"PMC_36795578","title":"Knockout of AMD-associated gene POLDIP2 reduces mitochondrial superoxide in human retinal pigment epithelial cells.","date":"2023","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/36795578","citation_count":2,"is_preprint":false},{"pmid":"42054341","id":"PMC_42054341","title":"Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19.","date":"2026","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/42054341","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.06.17.657579","title":"Poldip2 deficiency attenuates disease severity in a mouse model of COVID-19","date":"2025-06-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.17.657579","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.05.602318","title":"An adaptor for feedback regulation of heme biosynthesis by the mitochondrial protease CLPXP","date":"2024-07-07","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.05.602318","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":29490,"output_tokens":7881,"usd":0.103343,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17473,"output_tokens":6416,"usd":0.123883,"stage2_stop_reason":"end_turn"},"total_usd":0.227226,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"PDIP38 (POLDIP2) was identified as a binding partner of the p50 subunit of DNA polymerase delta and of PCNA, confirmed by GST pulldown assays, PCNA overlay experiments, co-immunoprecipitation from calf thymus and mammalian cell extracts, immunoaffinity chromatography, and native gel electrophoresis.\",\n      \"method\": \"Yeast two-hybrid, GST pulldown, PCNA overlay, co-immunoprecipitation, immunoaffinity chromatography, native gel electrophoresis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal biochemical methods (pulldown, overlay, CoIP, affinity chromatography) in a single rigorous study\",\n      \"pmids\": [\"12522211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PDIP38 localizes predominantly to the mitochondrial matrix (not nuclear) in HeLa cells, where it co-immunoprecipitates with mitochondrial transcription factor A (TFAM) and mitochondrial single-stranded DNA binding protein (mtSSB), and crosslinks to mtSSB, the 60 kDa heat shock protein, and a Lon protease homolog, indicating association with the mitochondrial DNA nucleoid.\",\n      \"method\": \"Subcellular fractionation, proteinase K protection assay, co-immunoprecipitation, formaldehyde crosslinking\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal CoIP plus crosslinking plus protease-protection fractionation, multiple orthogonal methods in one study\",\n      \"pmids\": [\"16428295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PDIP38 localizes to the mitotic spindle throughout mitosis, and its loss-of-function (antibody injection or siRNA silencing) causes spindle organization defects, aberrant chromosome segregation, and multinucleated cells.\",\n      \"method\": \"Immunofluorescence/live imaging, antibody microinjection, siRNA knockdown, cell biology assays\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiment with functional consequence via two independent loss-of-function approaches (antibody injection and siRNA), single lab\",\n      \"pmids\": [\"18843206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Poldip2 associates with p22phox, Nox1, and Nox4, colocalizes with p22phox at sites of Nox4 localization, and increases Nox4 enzymatic activity ~3-fold, thereby positively regulating basal ROS production (superoxide and H2O2) in vascular smooth muscle cells. Poldip2 overexpression activates RhoA, strengthens focal adhesions, and increases stress fiber formation; these effects are blocked by dominant-negative RhoA. Depletion of Poldip2 or Nox4 causes loss of these structures, rescued by active RhoA.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, colocalization, NADPH oxidase activity assay, ROS measurement, RhoA activation assay, dominant-negative rescue, siRNA knockdown, overexpression\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal CoIP, enzymatic activity assay, genetic epistasis (dominant-negative rescue), multiple orthogonal methods, widely replicated\",\n      \"pmids\": [\"19574552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PDIP38 directly interacts with TLS polymerase Polη via Polη's UBZ domain, and also interacts with Rev1 and Polζ (via Rev7). Depletion of PDIP38 increases Polη foci in undamaged cells and reduces cell survival after UV irradiation.\",\n      \"method\": \"Direct protein interaction assays, co-immunoprecipitation, siRNA knockdown, immunofluorescence, UV survival assay\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct interaction mapping to specific domain, functional consequence of knockdown, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"20554254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"In response to UV irradiation (or transcriptional stress), PDIP38 is translocated to nuclear speckles/spliceosomes, and its depletion (shRNA) greatly reduces UV-induced alternative splicing of MDM2 transcripts.\",\n      \"method\": \"Immunofluorescence with nuclear subcompartment markers, shRNA knockdown, nested RT-PCR for alternative splicing\",\n      \"journal\": \"Cell cycle (Georgetown, Tex.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional consequence (alternative splicing), two orthogonal methods, single lab\",\n      \"pmids\": [\"23989611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Poldip2 regulates focal adhesion turnover and VSMC migration via Nox4/RhoA/FAK-dependent signaling: overexpression blocks focal adhesion dissolution and sustains H2O2 in focal adhesions; Nox4 silencing prevents focal adhesion stabilization by Poldip2; RhoA inhibition blocks Poldip2-mediated attenuation of focal adhesion dissolution; overexpression of RhoA or FAK reverses the loss of focal adhesions induced by Poldip2 knockdown.\",\n      \"method\": \"Adenoviral overexpression, siRNA knockdown, live imaging of focal adhesion dynamics, RhoA activity assay, H2O2 measurement in focal adhesions, traction force microscopy\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis established by multiple rescue experiments (RhoA, FAK, Nox4), live imaging with functional readout, multiple orthogonal methods\",\n      \"pmids\": [\"25063792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In kidney myofibroblasts, RhoA/ROCK signaling acts upstream of Poldip2-dependent Nox4 regulation and ROS production during TGF-β1-induced myofibroblast activation; inhibition of RhoA (siRNA) or ROCK (Y-27632) significantly reduced Poldip2 and Nox4 protein and NADPH oxidase activity.\",\n      \"method\": \"siRNA knockdown, pharmacological inhibition (Y-27632), NADPH oxidase activity assay, Western blotting\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic and pharmacological epistasis, single lab, multiple inhibitor approaches\",\n      \"pmids\": [\"24872317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Poldip2 knockout mouse embryonic fibroblasts display reduced proliferation (not due to apoptosis or senescence), increased autophagy (elevated LC3b), G1/G2M arrest with reduced S-phase cells, increased p53 S20 phosphorylation and Sirt1, downregulation of Cdk1 and CyclinA2, and increased p21CIP1; the Cdk1/CyclinA2 changes are reversed by SV40 large T-antigen (implicating E2F pathway), while p21 increase is not.\",\n      \"method\": \"Gene-trap mouse model, flow cytometry, Western blotting, population doubling, SV40 large T-antigen rescue experiment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KO with defined cellular phenotype, partial pathway placement via SV40 rescue, single lab\",\n      \"pmids\": [\"24797518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"POLDIP2 promotes Tau aggregation through impairment of autophagy (and partially proteasome) activity; this activity resides in the DUF525 domain. Knockdown of Drosophila POLDIP2 homolog CG12162 attenuated Tau overexpression-induced neurodegeneration and extended lifespan of Tau(R406W) transgenic flies.\",\n      \"method\": \"cDNA expression library cell-based screen, ectopic overexpression/knockdown, Tau aggregation assay, autophagy/proteasome activity assay, domain deletion analysis, Drosophila genetic model\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — domain-level functional mapping, in vivo Drosophila validation, single lab\",\n      \"pmids\": [\"25930997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PolDIP2 directly interacts with PrimPol's catalytic domain, stimulates PrimPol's polymerase activity and processivity, enhances dNTP/DNA binding, and promotes error-free bypass of 8-oxoG lesions. PolDIP2 depletion in human cells reduces replication fork rates similarly to PrimPol-/- cells; PolDIP2 depletion in PrimPol-/- cells causes no further decrease, placing them in the same epistasis group.\",\n      \"method\": \"Protein interaction mapping, in vitro polymerase assay, processivity assay, 8-oxoG bypass assay, DNA fiber assay (replication fork rates), siRNA knockdown, epistasis analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro reconstitution of stimulation, mutagenesis/domain mapping, genetic epistasis, multiple orthogonal methods in one study\",\n      \"pmids\": [\"26984527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Poldip2 is a nuclear-encoded mitochondrial protein that controls lipoylation of pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase (αKGDH) complexes by regulating the ClpP protease complex and degradation of the lipoate-activating enzyme ACSM1. Poldip2 deficiency reduces lipoylation, represses mitochondrial respiration, stabilizes HIF-1α (via loss of substrate inhibition of PHDs), and induces metabolic reprogramming resembling hypoxia/cancer adaptation. Poldip2 expression is repressed by hypoxia and basally suppressed in triple-negative cancer cells.\",\n      \"method\": \"Genetic knockout/knockdown, metabolic flux analysis, lipoylation assays, mitochondrial respiration (Seahorse), HIF-1α stabilization assay, protease complex analysis, overexpression rescue\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal biochemical methods, mechanistic pathway dissection with rescue experiments, single rigorous study with broad validation\",\n      \"pmids\": [\"29434038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Poldip2/NOX4 activates NOX4 during integrin-mediated cell adhesion, leading to H2O2-mediated sulfenylation of filamentous actin (F-actin) at Cys272 and Cys374; oxidized F-actin promotes its binding to vinculin, facilitating focal adhesion maturation and cell migration. Depletion of Poldip2 or NOX4, or scavenging H2O2, inhibits F-actin oxidation; actin point mutants (C272A/C374A) that resist oxidation impair vinculin binding and migration.\",\n      \"method\": \"SiRNA knockdown, overexpression, H2O2 measurement, sulfenylation assay (DCP-Bio1), co-immunoprecipitation, point mutagenesis of actin, cell adhesion/migration assays\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — site-specific mutagenesis combined with biochemical assays and functional rescue, multiple orthogonal methods\",\n      \"pmids\": [\"30354218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Poldip2 knockdown in rat aortic smooth muscle cells reduces serum-induced proliferation and PCNA expression, and upregulates p21. siRNA-mediated downregulation of p21 rescues the proliferation inhibition caused by Poldip2 knockdown, placing p21 downstream of Poldip2 in VSMC proliferation control.\",\n      \"method\": \"siRNA knockdown, cell proliferation assay, Western blotting, epistasis by p21 siRNA rescue, neointima formation in mouse femoral artery wire injury model\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis (p21 rescue), in vivo and in vitro corroboration, single lab\",\n      \"pmids\": [\"30237457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Poldip2 mediates LPS-induced blood-brain barrier disruption by regulating NF-κB subunit p65 nuclear translocation and downstream Cox-2/prostaglandin E2 induction in brain endothelial cells; heterozygous deletion of Poldip2 protects against BBB permeability, and Cox-2 inhibition (meloxicam) reverses BBB disruption in WT but not Poldip2+/- mice.\",\n      \"method\": \"Poldip2+/- mouse model, Evans blue permeability assay, immunoblotting, ELISA, siRNA knockdown in brain endothelial cells, immunofluorescence of p65 translocation, FITC-dextran transwell assay\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic model corroborated by in vitro siRNA and pharmacological epistasis, multiple orthogonal methods\",\n      \"pmids\": [\"31779628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Poldip2 deficiency induces a highly differentiated VSMC phenotype through upregulation of the hexosamine biosynthetic pathway and OGT-mediated protein O-GlcNAcylation, which inhibits a nuclear ubiquitin proteasome system responsible for SRF stabilization and KLF4 repression; Poldip2-deficient VSMCs resist dedifferentiation and macrophage-like conversion in response to cholesterol or PDGF.\",\n      \"method\": \"Genetic knockdown/knockout (in vitro and in vivo mouse aorta), RNA-seq, Western blotting, UPS activity assays, OGT inhibition, cholesterol/PDGF challenge\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo and in vitro corroboration, mechanistic pathway placement via OGT inhibition and UPS activity assays, multiple orthogonal methods\",\n      \"pmids\": [\"31656131\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PDIP38 shifts DNA damage tolerance in mammalian and chicken cells from template switching (TS) toward translesion synthesis (TLS): PDIP38-/- cells show increased immunoglobulin gene conversion (TS) and reduced non-templated hypermutation (TLS) in DT40, and increased sister chromatid exchanges in both DT40 and human TK6 cells, without increased sensitivity to UV or H2O2.\",\n      \"method\": \"Gene disruption (CRISPR/gene targeting) in DT40 and TK6, Ig V gene sequence analysis, sister chromatid exchange assay, UV/H2O2 sensitivity assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis established in two independent cell systems with multiple assays, mechanistically defining TLS vs TS balance\",\n      \"pmids\": [\"30840704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Human PDIP38 is directed to the mitochondrial matrix in a membrane-potential-dependent manner. Its N-terminal YccV-like domain (SH3-like β-barrel) interacts specifically with CLPX via CLPX's N-terminal zinc-binding domain adaptor docking loop. Its C-terminal DUF525 domain forms an immunoglobulin-like β-sandwich with a conserved substrate-binding pocket. PDIP38 modulates CLPX substrate specificity and protects CLPX from LONM-mediated degradation, stabilizing cellular CLPX levels.\",\n      \"method\": \"Crystal structure, biochemical reconstitution, domain interaction mapping, mitochondrial import assay (membrane potential dependence), CLPXP substrate specificity assay, LONM degradation assay\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure with functional validation, biochemical reconstitution of CLPXP regulation, multiple orthogonal methods in one rigorous study\",\n      \"pmids\": [\"33159171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Crystal structure of POLDIP2 to 2.8 Å reveals a compact two-domain β-strand-rich globular fold comprising YccV (SH3-like β-barrel) and DUF525 (immunoglobulin-like β-sandwich) domains with a conserved central channel containing a modified cysteine residue; molecular dynamics reveals a highly dynamic N-terminal region tethered by an extended linker, which likely mediates interactions with binding partners including PrimPol and PCNA.\",\n      \"method\": \"X-ray crystallography, circular dichroism, SAXS, molecular dynamics simulation, ab initio modelling\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure at 2.8 Å with orthogonal SAXS and CD validation, single lab\",\n      \"pmids\": [\"33884680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PolDIP2 uses a flexible loop to interact with the C-terminal ApaG-like (DUF525) domain of PolDIP2 on PrimPol's catalytic domain; a unique arginine cluster in PolDIP2 is required for increasing PrimPol's primer-template and dNTP binding affinities, thereby enhancing nucleotide incorporation efficiency and processivity.\",\n      \"method\": \"In vitro polymerase assay, dNTP/DNA binding affinity measurements, mutagenesis of PolDIP2 arginine cluster, protein interaction mapping\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis of specific residues, binding affinity quantification, mechanistic dissection of stimulation mechanism\",\n      \"pmids\": [\"33533925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PolDIP2 directly interacts with Tau protein in vitro and inhibits Tau oligomer formation and amyloid fibril growth, as shown by thioflavin-T kinetic assays, Tau oligomer dot-blot, and atomic force microscopy single-molecule analysis.\",\n      \"method\": \"Thioflavin-T aggregation kinetics, Tau oligomer dot-blot, atomic force microscopy, direct protein interaction assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with multiple complementary methods, single lab, no cellular or in vivo validation in this study\",\n      \"pmids\": [\"34071254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Poldip2 promotes VCAM-1 induction in brain endothelial cells following ischemia via activation of focal adhesion kinase (FAK); FAK activation was identified as a critical intermediary in Poldip2-mediated VCAM-1 induction, and Poldip2 depletion in vivo attenuated myeloid cell infiltration and adhesion molecule induction after cerebral ischemia.\",\n      \"method\": \"Poldip2+/- mouse cerebral ischemia model, flow cytometry, RT-PCR, siRNA knockdown in brain endothelial cells, FAK activation assay, Western blotting\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo and in vitro corroboration, FAK epistasis established in vitro, single lab\",\n      \"pmids\": [\"33692398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Endothelial Poldip2 regulates sepsis-induced lung injury via RhoA pathway activation: endothelial-specific Poldip2 knockout reduces LPS-induced lung leukocyte infiltration, inflammatory gene expression, and VCAM1 induction; in vitro, Poldip2 knockdown reduces TNFα-induced endothelial permeability, VE-cadherin disruption, and RhoA activation, with redistribution of active RhoA away from cell edges.\",\n      \"method\": \"Endothelial-specific conditional knockout mouse, BAL/lung tissue analysis, qPCR, siRNA knockdown in human pulmonary endothelial cells, transendothelial resistance assay, VE-cadherin immunofluorescence, RhoA activity assay\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific in vivo knockout corroborated by in vitro mechanistic studies, multiple orthogonal methods\",\n      \"pmids\": [\"34528082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Poldip2 is repressed under hypoxia by a mechanism requiring activation of the EZH2 repressive complex downstream of CDK2; Poldip2 repression is required for CCN2/CTGF expression via metabolic inhibition of the ubiquitin-proteasome system leading to SRF stabilization; pharmacological or genetic CDK2 inhibition reverses Poldip2 downregulation, UPS inhibition, and fibrotic gene expression.\",\n      \"method\": \"Hypoxia exposure, CDK2 inhibition (pharmacological and siRNA), EZH2 inhibition, UPS activity assay, Western blotting, gene expression analysis\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway epistasis with multiple inhibitor approaches, single lab\",\n      \"pmids\": [\"36596387\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Myeloid Poldip2 is required for β2-integrin activation and Pyk2 phosphorylation in neutrophils, facilitating neutrophil adhesion to activated endothelium and transmigration; myeloid-specific Poldip2 knockout reduces LPS-induced lung leukocyte infiltration without affecting neutrophil surface β2-integrin expression, ROS production, NET formation, or cytokine induction.\",\n      \"method\": \"Myeloid-specific Poldip2 knockout mouse, BAL cell counts, β2-integrin activation assay, Pyk2 phosphorylation, neutrophil adhesion/transmigration assay, ROS assay, NET formation assay\",\n      \"journal\": \"Journal of the American Heart Association\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-type-specific KO with mechanistic dissection (integrin activation, Pyk2), single lab, multiple functional readouts\",\n      \"pmids\": [\"35535614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Poldip2 negatively modulates NADPH oxidase 2 (Nox2) activity in neutrophil membranes (~2.5-fold downregulation) by interacting with the regulatory subunit p47phox (not p22phox), trapping p47phox and preventing Nox2 assembly; this is opposite to its positive regulation of Nox4.\",\n      \"method\": \"In vitro NADPH oxidase activity assay with fractionated neutrophil membranes, recombinant purified Poldip2, protein interaction assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified proteins, mechanistic distinction from Nox4 regulation, single lab\",\n      \"pmids\": [\"36828293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"POLDIP2 serves as a heme-sensing adaptor protein for the mitochondrial protease CLPXP: it directly recognizes heme-bound ALAS and drives assembly of the ALAS-CLPXP degradation complex for heme-induced negative feedback degradation of ALAS; loss of POLDIP2 strongly impairs ALAS turnover in cells. The C-terminal element of ALAS (truncated in X-linked dominant protoporphyria) is dispensable for POLDIP2 interaction but required for CLPXP-mediated degradation.\",\n      \"method\": \"Biochemical reconstitution, pulldown with heme-bound ALAS, ALAS turnover assay in cells (POLDIP2 knockout), domain deletion analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of the full degradation complex, cellular validation of ALAS turnover, mechanistic domain dissection, single rigorous preprint\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In Drosophila spermatogenesis, Poldip2 is a mitochondrial matrix protein that binds mtDNA and is required for paternal mtDNA elimination; disruption of poldip2 causes substantial mtDNA retention in mature sperm and paternal mtDNA transmission. ClpX (key CLPXP component) interacts with Poldip2 and co-regulates mtDNA elimination in spermatids.\",\n      \"method\": \"Forward genetic screen, genetic disruption, imaging, biochemical analyses, ChIP assay, co-immunoprecipitation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — forward genetic screen, ChIP and CoIP validation, functional consequence in vivo, single lab in Drosophila model\",\n      \"pmids\": [\"39934413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Poldip2 promotes SMAD3 activation and facilitates its nuclear translocation by directly interacting with SMAD3, enhancing expression of fibrosis markers (MMP9, COL-1, FN, CTGF) via TGF-β1/SMAD3 signaling in retinal pigment epithelial cells exposed to high glucose.\",\n      \"method\": \"siRNA/shRNA knockdown (in vitro and in vivo AAV9), co-immunoprecipitation (Poldip2-SMAD3 interaction), Western blotting, immunofluorescence of SMAD3 nuclear translocation\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CoIP establishing direct interaction, nuclear translocation assay, in vivo and in vitro corroboration, single lab\",\n      \"pmids\": [\"38968428\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLDIP2 (PDIP38) is a multifunctional mitochondrial matrix adaptor protein that: (1) activates Nox4 (and negatively regulates Nox2 via p47phox interaction) to generate H2O2 for cytoskeletal remodeling—oxidizing F-actin to promote vinculin binding, focal adhesion maturation, and VSMC migration via RhoA/FAK; (2) controls mitochondrial oxidative metabolism by regulating ClpP protease-dependent degradation of ACSM1 to maintain PDH and αKGDH lipoylation, and serves as a heme-sensing adaptor delivering ALAS to CLPXP for negative-feedback degradation; (3) interacts with and stimulates replication-associated polymerases (DNA pol δ p50/PCNA, PrimPol via its DUF525 arginine cluster, and TLS polymerases Polη, Rev1, Polζ), shifting DNA damage tolerance toward translesion synthesis; (4) localizes to the mitotic spindle where it is required for chromosome segregation; and (5) translocates to nuclear speckles upon UV stress to facilitate MDM2 alternative splicing.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POLDIP2 (PDIP38) is a compact two-domain adaptor protein—an N-terminal YccV-like SH3 β-barrel and a C-terminal DUF525 immunoglobulin-like β-sandwich [#18]—that operates as a multifunctional scaffold across mitochondrial, redox, and DNA-transaction processes. In mitochondria, where it is imported to the matrix in a membrane-potential-dependent manner and associates with the mtDNA nucleoid [#1, #17], it controls oxidative metabolism by regulating the ClpP/CLPXP protease: its YccV domain docks CLPX while its DUF525 domain shapes substrate specificity and protects CLPX from LONM-mediated degradation [#17]. Through this protease axis POLDIP2 governs ClpP-dependent turnover of the lipoate-activating enzyme ACSM1 to maintain PDH and αKGDH lipoylation and mitochondrial respiration, with its loss stabilizing HIF-1α and reprogramming metabolism [#11], and it acts as a heme-sensing adaptor that delivers heme-bound ALAS to CLPXP for negative-feedback degradation [#26]. As a redox regulator, POLDIP2 binds the NADPH oxidase subunit p22phox and Nox4, activating Nox4-derived H2O2 to drive RhoA/FAK-dependent focal adhesion maturation and vascular smooth muscle cell migration—including sulfenylation of F-actin at Cys272/Cys374 that promotes vinculin binding [#3, #6, #12]—while conversely restraining Nox2 by sequestering p47phox [#25]. In DNA metabolism, POLDIP2 binds the p50 subunit of DNA polymerase δ and PCNA [#0] and directly stimulates the polymerase activity and processivity of PrimPol via an arginine cluster in its DUF525 domain, promoting error-free 8-oxoG bypass and supporting replication fork progression in the same epistasis group as PrimPol [#10, #19]; it also engages translesion polymerases (Polη, Rev1, Polζ) and shifts DNA damage tolerance from template switching toward translesion synthesis [#4, #16]. POLDIP2 additionally localizes to the mitotic spindle and is required for proper chromosome segregation [#2]. In vivo, endothelial, myeloid, and vascular POLDIP2 promote inflammatory adhesion, barrier disruption, and fibrotic signaling through RhoA, FAK/Pyk2-integrin, NF-κB, and TGF-β1/SMAD3 pathways [#14, #22, #24, #28].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Established POLDIP2's first molecular partners, linking it to the replication/repair machinery before any pathway context existed.\",\n      \"evidence\": \"Yeast two-hybrid plus orthogonal biochemistry (GST pulldown, PCNA overlay, CoIP) identifying binding to DNA pol δ p50 and PCNA\",\n      \"pmids\": [\"12522211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No functional consequence of the interaction defined\", \"No structural basis for binding established at this stage\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolved where POLDIP2 acts by showing it is predominantly a mitochondrial matrix nucleoid protein, reframing it beyond a nuclear polymerase factor.\",\n      \"evidence\": \"Subcellular fractionation, proteinase K protection, CoIP and crosslinking to TFAM, mtSSB, HSP60 and a Lon homolog in HeLa cells\",\n      \"pmids\": [\"16428295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role at the nucleoid not defined\", \"Relationship between mitochondrial and nuclear pools unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Added a mitotic function, showing POLDIP2 is required for spindle integrity and chromosome segregation.\",\n      \"evidence\": \"Immunofluorescence/live imaging plus antibody microinjection and siRNA loss-of-function in mammalian cells\",\n      \"pmids\": [\"18843206\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular partners at the spindle unidentified\", \"Mechanism connecting spindle role to other functions unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined POLDIP2 as a positive regulator of Nox4-derived ROS driving cytoskeletal/focal adhesion remodeling, opening its redox-signaling role.\",\n      \"evidence\": \"Y2H, reciprocal CoIP with p22phox/Nox4, NADPH oxidase activity and ROS assays, RhoA activation, dominant-negative RhoA rescue in VSMCs\",\n      \"pmids\": [\"19574552\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular target of H2O2 in the cytoskeleton not yet identified\", \"Link to mitochondrial functions unaddressed\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected POLDIP2 to translesion synthesis by mapping direct interactions with TLS polymerases and a UV-survival phenotype.\",\n      \"evidence\": \"Direct interaction assays (Polη UBZ domain, Rev1, Polζ via Rev7), siRNA knockdown, Polη foci imaging, UV survival in human cells\",\n      \"pmids\": [\"20554254\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Directionality of TLS regulation not quantified\", \"In vitro reconstitution of polymerase stimulation absent\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established mechanistic epistasis placing POLDIP2 upstream of Nox4/RhoA/FAK in focal adhesion turnover and migration, and embedded it in a RhoA/ROCK feedback loop.\",\n      \"evidence\": \"Adenoviral overexpression, siRNA, live focal-adhesion imaging, traction force microscopy, RhoA/FAK rescue in VSMCs; RhoA/ROCK inhibition in kidney myofibroblasts\",\n      \"pmids\": [\"25063792\", \"24872317\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct oxidative substrate still not identified at this stage\", \"Generalizability beyond vascular/fibroblast cells unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked POLDIP2 loss to a cell-cycle/proliferation phenotype, implicating E2F-driven Cdk1/CyclinA2 and p21 control.\",\n      \"evidence\": \"Gene-trap knockout MEFs, flow cytometry, Western blotting, SV40 large T-antigen rescue\",\n      \"pmids\": [\"24797518\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting POLDIP2 to E2F/p21 not defined\", \"p21 increase not explained by the SV40-rescuable pathway\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated direct enzymatic stimulation of PrimPol by POLDIP2, defining a concrete replication-fork function and shared epistasis group.\",\n      \"evidence\": \"Interaction mapping to PrimPol catalytic domain, in vitro polymerase/processivity and 8-oxoG bypass assays, DNA fiber assays, epistasis with PrimPol-/-\",\n      \"pmids\": [\"26984527\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Residue-level basis of stimulation not yet mapped\", \"Contribution of mitochondrial vs nuclear pool unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined POLDIP2's mitochondrial metabolic role through ClpP-dependent ACSM1 turnover controlling lipoylation, respiration, and HIF-1α stability.\",\n      \"evidence\": \"Knockout/knockdown, metabolic flux, lipoylation assays, Seahorse respiration, HIF-1α stabilization, protease analysis, rescue\",\n      \"pmids\": [\"29434038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical link between POLDIP2 and ClpP activity not yet structurally defined\", \"Cancer relevance correlative\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified the molecular target of Nox4-derived H2O2 as F-actin, showing site-specific cysteine sulfenylation promotes vinculin binding and migration.\",\n      \"evidence\": \"siRNA/overexpression, DCP-Bio1 sulfenylation assay, CoIP, actin C272A/C374A point mutants, adhesion/migration assays\",\n      \"pmids\": [\"30354218\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Spatial coupling of Nox4 to actin not structurally resolved\", \"Whether mitochondrial POLDIP2 contributes to this pool unaddressed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended the proliferation phenotype to vascular pathology, placing p21 downstream of POLDIP2 in VSMC proliferation and neointima formation.\",\n      \"evidence\": \"siRNA in rat aortic SMCs, proliferation/PCNA assays, p21 siRNA rescue, mouse femoral artery wire-injury model\",\n      \"pmids\": [\"30237457\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of p21 regulation by POLDIP2 unknown\", \"Relationship to redox vs metabolic functions unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the directionality of POLDIP2 in DNA damage tolerance, showing it biases the balance from template switching toward translesion synthesis.\",\n      \"evidence\": \"Gene disruption in DT40 and TK6, Ig V gene conversion/hypermutation analysis, sister chromatid exchange, UV/H2O2 sensitivity assays\",\n      \"pmids\": [\"30840704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Substrate selectivity among TLS polymerases not quantified\", \"No structural basis for TS-vs-TLS choice\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Expanded POLDIP2 into vascular phenotype control and inflammation, connecting it to O-GlcNAcylation/SRF/KLF4 and NF-κB/Cox-2 pathways.\",\n      \"evidence\": \"In vivo/in vitro knockout, RNA-seq, UPS activity and OGT inhibition assays (VSMC differentiation); Poldip2+/- mice, p65 translocation and Cox-2 epistasis (BBB)\",\n      \"pmids\": [\"31656131\", \"31779628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target linking POLDIP2 to OGT/UPS not identified\", \"How a single adaptor coordinates these divergent pathways unresolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Provided the structural and biochemical basis for mitochondrial adaptor function, showing domain-specific CLPX docking and protection from LONM degradation.\",\n      \"evidence\": \"Crystal structure, reconstitution, domain interaction mapping, import assay, CLPXP substrate-specificity and LONM degradation assays\",\n      \"pmids\": [\"33159171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of CLPXP substrates POLDIP2 selects not enumerated\", \"Regulation of POLDIP2 import in vivo unaddressed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Delivered the full POLDIP2 structure and identified the DUF525 arginine cluster as the determinant of PrimPol stimulation.\",\n      \"evidence\": \"X-ray crystallography, CD, SAXS, MD simulation; in vitro polymerase and dNTP/DNA binding assays with arginine-cluster mutagenesis\",\n      \"pmids\": [\"33884680\", \"33533925\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Role of the dynamic N-terminus in partner selection not fully defined\", \"How one fold supports both mitochondrial and replication functions unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Probed a direct POLDIP2–Tau interaction, with conflicting cellular versus in vitro effects on Tau aggregation.\",\n      \"evidence\": \"In vitro ThT kinetics, dot-blot, AFM (inhibits aggregation); earlier cell/Drosophila screen mapping pro-aggregation to DUF525\",\n      \"pmids\": [\"34071254\", \"25930997\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro and cellular outcomes are opposite and unreconciled\", \"Physiological relevance to neurodegeneration uncertain\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established cell-type-specific in vivo roles in inflammation, dissecting endothelial RhoA/permeability and myeloid integrin/Pyk2 contributions.\",\n      \"evidence\": \"Endothelial-specific KO (sepsis lung injury, RhoA/VE-cadherin); myeloid-specific KO (β2-integrin activation, Pyk2); hypoxia/CDK2/EZH2 repression of POLDIP2\",\n      \"pmids\": [\"34528082\", \"35535614\", \"36596387\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether redox vs scaffolding activity drives each phenotype unresolved\", \"Upstream signals selecting which pathway POLDIP2 engages unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Distinguished POLDIP2's opposing NADPH oxidase regulation, showing direct p47phox sequestration suppresses Nox2 assembly.\",\n      \"evidence\": \"In vitro NADPH oxidase assays with fractionated neutrophil membranes and recombinant POLDIP2, protein interaction assays\",\n      \"pmids\": [\"36828293\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of p47phox sequestration not defined\", \"In vivo relevance of Nox2 suppression not established\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined POLDIP2 as a heme-sensing adaptor coupling ALAS turnover to CLPXP, integrating its protease-adaptor role with heme homeostasis.\",\n      \"evidence\": \"Biochemical reconstitution, pulldown of heme-bound ALAS, ALAS turnover in POLDIP2-KO cells, domain deletion (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"Disease relevance to X-linked protoporphyria correlative\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Showed a conserved in vivo mitochondrial function for the POLDIP2–ClpX axis in paternal mtDNA elimination during spermatogenesis.\",\n      \"evidence\": \"Forward genetic screen, genetic disruption, imaging, ChIP and CoIP in Drosophila\",\n      \"pmids\": [\"39934413\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of mtDNA-targeted elimination not defined\", \"Conservation in mammalian spermatogenesis untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unknown how a single small two-domain adaptor mechanistically partitions among its mitochondrial protease, NADPH oxidase redox, replication/TLS polymerase, and spindle roles, and what regulates its distribution between organelles.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No unified model of pool partitioning between mitochondria and nucleus\", \"No structure of POLDIP2 bound to its replication or oxidase partners\", \"Regulation of context-specific function selection unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [17, 26, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10, 19, 25, 17]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [10, 19]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 27]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [1, 11, 17, 27]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 5]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [12, 3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [11, 26]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [0, 10, 19]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [4, 16]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [17, 11, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 6, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [14, 22, 24]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"complexes\": [\"CLPXP protease\", \"NADPH oxidase (Nox4/p22phox)\", \"mtDNA nucleoid\"],\n    \"partners\": [\"CLPX\", \"PrimPol\", \"PCNA\", \"Nox4\", \"p22phox\", \"p47phox\", \"TFAM\", \"SMAD3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}